General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-13 | 2024-06 | -1.06 | N/A | N/A | N/A |
2024-05-09 | 2024-03 | -1.16 | -1.26 | -0.1 | -8.62% |
2024-03-14 | 2023-12 | -0.82 | -1.02 | -0.2 | -24.39% |
2023-11-08 | 2023-09 | -0.92 | -0.75 | 0.17 | 18.48% |
2023-08-08 | 2023-06 | -1.13 | -1.37 | -0.24 | -21.24% |
2023-05-09 | 2023-03 | -1.08 | -0.96 | 0.12 | 11.11% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-28 | B. Riley Securities | Upgrade | Buy | Buy |
2023-09-26 | B. Riley Securities | Upgrade | Buy | |
2023-08-28 | Mizuho | Upgrade | Buy | Buy |
2023-08-08 | RBC Capital | Upgrade | Outperform | Outperform |
2023-07-10 | Truist Securities | Upgrade | Buy | Buy |
2023-07-05 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-17 | BUNN PAUL A M.D. | Director | 8.33K | Stock Award(Grant) |
2024-06-19 | CALKINS DANIEL | Chief Financial Officer | 47.32K | Sale |
2024-06-19 | GAGNON ROBERT E | Director | 35.31K | Sale |
2024-06-17 | JOHNSON JOHN H | Director | 8.33K | Stock Award(Grant) |
2024-06-17 | KAPUR ANIL | Director | 8.33K | Stock Award(Grant) |
2024-06-17 | KAUFFMAN MICHAEL G | Director | 8.88K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Viking Global Investors, L.P. | 1.89M | 14.03M | 7.47% |
2023-06-29 | BVF Inc. | 1.69M | 12.54M | 6.67% |
2023-06-29 | Deerfield Management Company, L.P. (Series C) | 1.54M | 11.45M | 6.09% |
2023-06-29 | Vivo Capital, LLC | 1.54M | 11.45M | 6.09% |
2023-06-29 | Orbimed Advisors LLC. | 1.53M | 11.38M | 6.06% |
2023-06-29 | Baker Brothers Advisors, LLC | 1.34M | 9.94M | 5.29% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 746.25K | 5.55M | 2.96% |
2023-06-29 | Vanguard Extended Market Index Fund | 220.01K | 1.64M | 0.87% |
2023-06-29 | Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 150.00K | 1.12M | 0.59% |
2023-05-30 | Fidelity Extended Market Index Fund | 79.92K | 978.25K | 0.32% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 29.58K | 220.10K | 0.12% |
2023-05-30 | Fidelity Total Market Index Fund | 26.63K | 326.00K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2023-06-01 |
Here we go, Bryan. Congrats!
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
The 2023 Annual Meeting of Stockholders (the “Annual Meeting”) of Verastem, Inc. (the “Company” or “Verastem”) will be held on Monday, May 15, 2023, at 9:00 a.m. Eastern Time, at the Company’s offices, 117 Kendrick Street, Suite 500, Needham, Massachusetts 02494.
Proxy materials, which include a Notice of the Internet Availability of Proxy Materials, Proxy Statement and proxy card, accompany this letter. The enclosed proxy statement is first being mailed or made available to stockholders of Verastem, Inc. on or about April 5, 2023. At the Annual Meeting, you will be asked to consider and vote: